Article: Geron Announces Second Interference Over Nuclear Transfer Patents.

Business Editors/Health & Medical Writers

MENLO PARK, Calif.--(BW HealthWire)--March 11, 2002

Geron Corporation (Nasdaq: GERN) announced today that the U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences, has declared a second interference involving one of the series of patent applications covering nuclear transfer technology licensed to Geron from the Roslin Institute.

In February, Geron announced that the Patent Office had granted Geron's request for an interference between a Roslin/Geron patent application and a University of Massachusetts patent licensed to Advanced Cell Technology, Inc. of Worcester, Massachusetts. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!